• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wellgistics Health Inc. filed SEC Form 8-K: Leadership Update

    10/10/25 4:15:52 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care
    Get the next $WGRX alert in real time by email
    false 0002030763 0002030763 2025-10-06 2025-10-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): October 6, 2025

     

    WELLGISTICS HEALTH, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-42530   93-3264234

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    3000 Bayport Drive

    Suite 950

    Tampa, FL 33607

    (Address of principal executive offices, including zip code)

     

    Registrant’s telephone number, including area code: (844) 203-6092

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

      ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
         
      ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
         
      ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
         
      ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
             
    Common Stock, $0.0001 par value per share   WGRX   The Nasdaq Capital Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    Officer Resignations

     

    On October 6, 2025, Brian Norton advised the Company that he was resigning from his position as Chief Executive Officer of the Corporation effective Monday, October 6, 2025, at 5:00 p.m. EST.

     

    On October 6, 2025, Tony Madsen advised the Company that he was resigning from his position as Chief Operating Officer of the Corporation effective Monday, October 6, 2025, at 8:00 p.m. EST.

     

    On October 6, 2025, Mark DiSiena advised the Company that he was resigning from his position as Chief Financial Officer of the Corporation effective Monday, October 6, 2025, at 5:00 p.m. EST.

     

    Appointment of Officer

     

    On October 7, 2025, Eric Sherb was appointed as the interim Chief Financial Officer of the Company by the board of directors.

     

    Eric Sherb (age: 38) serves as the chief financial officer of Crown Reserve Acquisition Corp. I. He is a CPA with 16 years of experience in accounting advisory, auditing and mergers and acquisitions. Mr. Sherb began his career at PricewaterhouseCoopers in New York City in a variety of industries from hedge funds to manufacturing and healthcare. Following his time at PricewaterhouseCoopers, Mr. Sherb served as Audit Manager at RBSM LLP, and Senior Manager at CFGI. Since October 2018, Mr. Sherb has been a founder and owner of EMS Consulting Services, LLC. Mr. Sherb has extensive experience in financial reporting and governance within the capital markets, including IPOs, direct listings, SPAC and de-SPAC transactions. He has served as chief financial officer and provided financial consultancy services for several NASDAQ and OTC clients, most recently, Scienture Holdings (NASDAQ: SCNX). Mr. Sherb has successfully assisted companies with IPO and audit readiness, registration statement filings, coordination with other stakeholders (legal, underwriters, transfer agent, edgarizers, etc), and ongoing SEC and PCAOB compliance.

     

    On September 8, 2025, the Company entered into a Consulting Agreement with EMS Consulting Services, Inc., an entity controlled by Mr. Sherb (the “IC Agreement”), in connection with Mr. Sherb’s appointment as a consultant of the Company. The IC Agreement has been amended to reflect Mr. Sherb’s role as the interim Chief Financial Officer of the Company. Under the IC Agreement, Mr. Sherb has agreed to perform various financial services to the Company typical of a Chief Financial Officer of a publicly-traded company with common stock listed on The Nasdaq Marketplace LLC. In exchange, the Company has agreed to pay Mr. Sherb an hourly rate equal to $185 per hour for CPA services and $80 per hour for services related to bookkeeping or the controller team. The IC Agreement became effective on September 8, 2025, and may be terminated by either party at any time.

     

    There are no family relationships between Mr. Sherb and any director, executive officer or nominees thereof of the Company. There are no related party transactions between the Company and Mr. Sherb that would require disclosure under Item 404(a) of Regulation S-K under the Securities Exchange Act of 1934, as amended.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: October 10, 2025 WELLGISTICS HEALTH, INC.
         
      By: /s/ Prashant Patel
        Prashant Patel, President

     

     

     

    Get the next $WGRX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WGRX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WGRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Fell Donald G.

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/21/25 3:04:46 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    SEC Form 3 filed by new insider Lee Steven Dale

    3 - Wellgistics Health, Inc. (0002030763) (Issuer)

    10/14/25 4:45:31 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Director Peterson Michael L gave a grant of 200,000 shares, decreasing direct ownership by 50% to 200,000 units (SEC Form 4)

    4 - Wellgistics Health, Inc. (0002030763) (Issuer)

    7/8/25 5:15:29 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DataVault AI and Wellgistics Health Announce Plans for PharmacyChain™ to Implement Manufacturer-to-Patient Blockchain-enabled Smart Contracts for the Prescription Drug Industry to Improve Efficiency and Patient Outcomes

    BEAVERTON, Ore., Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- DataVault AI, Inc. ("DataVault") (NASDAQ:DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts ("PharmacyChain™") into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry. The goal of the partnership will be to seek to fully digitize t

    10/22/25 6:05:00 AM ET
    $DVLT
    $WGRX
    Semiconductors
    Technology
    Other Pharmaceuticals
    Health Care

    WGRX CEO Brian Norton to Go Live on Floorstocks YouTube — Unfiltered Market Talk at 1 PM EST

    NEW YORK, July 22, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a growing force in pharmaceutical distribution and healthcare technology, will appear live on YouTube via the Floorstocks channel (@floorstocks) this Tuesday, July 22 at 1:00 PM EST. CEO Brian Norton will participate in an unfiltered discussion covering WGRX's recent momentum, stock performance, market outlook, and the company's strategy ahead. Floorstocks—the platform known for amplifying rising public companies—will host this live session, providing retail investors direct engagement. Why Tune In? Hear firsthand insight from CEO Brian Norton on the company's latest developmentsDeep dive into WGRX

    7/22/25 4:27:53 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX)

    NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Floorstocks, a financial media platform with over 1.2 million active retail investors, has released an exclusive CEO interview filmed at the Nasdaq MarketSite with Brian Norton, CEO of Wellgistics Health Inc. (NASDAQ:WGRX). The full interview is now available on YouTube and Floorstocks.com, offering investors a front-row look at one of healthcare's most disruptive emerging growth companies. Watch the full interview on YouTube:https://youtu.be/gJJlbqd7Mv8 Also streaming at Floorstocks.com:https://www.floorstocks.com Hosted by market veteran Kenneth Polcari, the interview unpacks how Wellgistics is modernizing the $600+ billion U.S. prescription

    7/10/25 11:46:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    SEC Filings

    View All

    Wellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    10/22/25 8:41:18 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    SEC Form PRE 14C filed by Wellgistics Health Inc.

    PRE 14C - Wellgistics Health, Inc. (0002030763) (Filer)

    10/21/25 5:17:45 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wellgistics Health, Inc. (0002030763) (Filer)

    10/17/25 4:58:28 PM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    $WGRX
    Financials

    Live finance-specific insights

    View All

    Wellgistics Health Secures $50M ELOC facility for XRP Treasury Reserve & Real-Time Payments Infrastructure and other general ops

    Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity

    5/8/25 9:00:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care

    Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative

    Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner. This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity

    5/8/25 7:05:00 AM ET
    $WGRX
    Other Pharmaceuticals
    Health Care